Search
SOLACI Congress
HomeStructural heart diseaseValvular Aortic valve

Valvular Aortic valve

View Category

Structural heart disease

Valve Deterioration after TAVI Is Rare and Should Not Prevent Advancement to Younger Populations

Durability ─or better yet, lack of deterioration─ is still a matter of debate when considering transcatheter aortic...
solaci -
Learn More
DAY 3

SOLACI CACI 2017 | When is the optimal timing for PCI: before or during TAVI

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Conrad...
solaci -
Learn More
DAY 3

SOLACI CACI 2017 | TAVI intermediate risk: Reality or passion?

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Flavio...
solaci -
Learn More
Structural heart disease

SOLACI CACI 2017 | Prevention of valvular thrombosis: antiaggregation or anticoagulation?

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr....
solaci -
Learn More
DAY 3

SOLACI CACI 2017 | How to do a MitraClip simple and fast

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Saibal...
solaci -
Learn More
DAY 3

SOLACI CACI 2017 | TAVI: Clinical Evidence of long term durability of prosthetic valves

Read articles on the main presentations of the third day of SOLACI-CACI 2017 Congress. See the presentation by Dra. Carla...
solaci -
Learn More
Day 2

SOLACI CACI 2017 | Clinical evidence of TAVR in intermediate risk patients: Lessons from clinical trials

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Andreas...
solaci -
Learn More
Day 2

SOLACI CACI | TAVI: Evidencia para pacientes de riesgo intermedio

Read articles on the main presentations of the second day of SOLACI-CACI 2017 Congress. See the presentation by Dr. Oscar...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Dr. Juan Manuel Pérez - 0
Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

Dr. Juan Manuel Pérez - 0
TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Institutional News

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy